European urology

Keyphrases

Publications

volume 86, number 2, 2024

Nicholas G Nickols, Sonny Tsai, Nathanael Kane, Samantha Tran, Leila Ghayouri, Silvia Diaz-Perez, May Thein, Nancy Anderson-Berman, Jeanie Eason, Amar U Kishan, Michael L Steinberg, Robert E Reiter, Steve P Lee, Greg E Gin, Robert Kwon, Michael G Chang, Hann-Hsiang Chao, Abhiskek A Solanki, Rachael Sexton, Michael Lewis, William Lorentz, Michael K Cheung, Diana L Gage, Sai Duriseti, Luca Valle, Gholam Berenji, William J Aronson, Isla P Garraway, Matthew B Rettig
Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer. European urology 86 (2) (2024)
Laura Elst, Gino Philips, Kaat Vandermaesen, Ayse Bassez, Francesca Lodi, Manon T A Vreeburg, Oscar R Brouwer, Rogier Schepers, Thomas Van Brussel, Sambit K Mohanty, Anil V Parwani, Lien Spans, Isabelle Vanden Bempt, Gerd Jacomen, Marcella Baldewijns, Diether Lambrechts, Maarten Albersen
Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization. European urology 86 (2) (2024)
Jeremy Yuen-Chun Teoh, Cheung-Hing Cheng, Chiu-Fung Tsang, Joseph Kai-Man Li, Bryan Kwun-Chung Cheng, Wilson Hoi-Chak Chan, Wayne Kwun-Wai Chan, Trevor Churk-Fai Li, Yi Chiu, Man-Chung Law, Clarence Lok-Hei Leung, Brian Sze-Ho Ho, Chris Yue-Kit Lee, Ronald Cheong-Kin Chan, Eddie Shu-Yin Chan, Marco Tsz-Yeung Chan, James Hok-Leung Tsu, Ho-Man Tam, Kin-Man Lam, Hing-Shing So, Chak-Lam Cho, Chi-Man Ng, Chun-Ki Chan, Pak-Ling Liu, Ringo Wing-Hong Chu, Ada Tsui-Lin Ng, Sau-Kwan Chu, Chi-Hang Yee, Ming-Kwong Yiu, Ka-Lun Lo, Wing-Hang Au, Wai-Kit Ma, Peter Ka-Fung Chiu, Hilda Sze-Wan Kwok, Siu-Ying Yip, Chi-Ho Leung, Chi-Fai Ng, null null
Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial. European urology 86 (2) (2024)
Marie-Pier St-Laurent, Peter C Black
Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression. European urology 86 (2) (2024)
Marcus J Drake, Lori A Birder
Re: EV-301 Long-term Outcomes: 24-month Findings from the Phase III Trial of Enfortumab Vedotin Versus Chemotherapy in Patients with Previously Treated Advanced Urothelial Carcinoma. European urology 86 (2) (2024)
Marcus J Drake, Lori A Birder
Re: EV-301 Long-term Outcomes: 24-month Findings from the Phase III Trial of Enfortumab Vedotin Versus Chemotherapy in Patients with Previously Treated Advanced Urothelial Carcinoma. European urology 86 (2) (2024)
Vipul Patel, Jacques Marescaux, Marcio Covas Moschovas
The Humanitarian Impact of Telesurgery and Remote Surgery in Global Medicine. European urology 86 (2) (2024)
Sabine D Brookman-May, Marc Buyse, Stephen J Freedland, Branko Miladinovic, Ke Zhang, Wolfgang P Fendler, Felix Feng, Oliver Sartor, Christopher J Sweeney
Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate Cancer. European urology 86 (2) (2024)
Marie-Pier St-Laurent, Peter C Black
Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression. European urology 86 (2) (2024)
Markus Grabbert, Nikolaos Liakos, Christian Gratzke
Re: Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer. European urology 86 (2) (2024)
Viria Beccia, Giada Pinterpe, Roberto Iacovelli
Re: Thomas Powles, Zoe June Assaf, Viraj Degaonkar, et al. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma. Eur Urol 2024;85:114-22. European urology 86 (2) (2024)
Olivier Cussenot, Antoine Chambaz, Freddie C Hamdy
Re: Annika Herlemann, Janet E. Cowan, Samuel L. Washington 3rd, et al. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2024;85:565-573. European urology 86 (2) (2024)
null Chao-Yang, Yuan-Yuan Bao, Yuan-Yuan Yang, Chang-Kun Mao
Re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol 2024;85:146-53. European urology 86 (2) (2024)
Stefano Mancon, Heidemarie Ofner, David D'Andrea
Re: Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-year Outcomes from a Randomized Controlled Trial. European urology 86 (2) (2024)
Philip Cornford, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann M Henry, Michael Lardas, Geert J L H van Leenders, Matthew Liew, Estefania Linares Espinos, Jan Oldenburg, Inge M van Oort, Daniela E Oprea-Lager, Guillaume Ploussard, Matthew J Roberts, Olivier Rouvière, Ivo G Schoots, Natasha Schouten, Emma J Smith, Johan Stranne, Thomas Wiegel, Peter-Paul M Willemse, Derya Tilki
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. European urology 86 (2) (2024)
Marko Babjuk
Can an En Bloc Technique Improve Outcomes of Endoscopic Surgery for Non-muscle-invasive Bladder Cancer? European urology 86 (2) (2024)
Ian M Thompson
Prostate-specific Antigen Screening in Limbo: How Low Should We Go? European urology 86 (2) (2024)
Jad Chahoud, Xiaoqing Yu, Andrea Necchi, Philippe E Spiess
TP53 Mutations Emerge as a Critical Biomarker in Penile Cancer, Superseding Human Papillomavirus Status. European urology 86 (2) (2024)
Fredrik Möller, Marianne Månsson, Jonas Wallström, Mikael Hellström, Jonas Hugosson, Rebecka Arnsrud Godtman
Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial. European urology 86 (2) (2024)
Philip Cornford, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann M Henry, Michael Lardas, Geert J L H van Leenders, Matthew Liew, Estefania Linares Espinos, Jan Oldenburg, Inge M van Oort, Daniela E Oprea-Lager, Guillaume Ploussard, Matthew J Roberts, Olivier Rouvière, Ivo G Schoots, Natasha Schouten, Emma J Smith, Johan Stranne, Thomas Wiegel, Peter-Paul M Willemse, Derya Tilki
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. European urology 86 (2) (2024)
Qi-Fei Deng, Yuan-Yuan Bao, Yuan-Yuan Yang, Chang-Kun Mao
Re: David Musheyev, Alexander Pan, Stacy Loeb, Abdo E. Kabarriti. How Well Do Artificial Intelligence Chatbots Respond to the Top Search Queries About Urological Malignancies? Eur Urol 2023;85:13-6. European urology 86 (2) (2024)
Jim C Hu, Mohamad E Allaf, Andrew J Vickers, Edward M Schaeffer
Reply to Giancarlo Marra, Marco Oderda, Paolo Gontero, and Lorenzo Richiardi's Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61-68. European urology 86 (2) (2024)
null Chao-Yang, Yuan-Yuan Bao, Yuan-Yuan Yang, Chang-Kun Mao
Re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol 2024;85:146-53. European urology 86 (2) (2024)
Fredrik Möller, Marianne Månsson, Jonas Wallström, Mikael Hellström, Jonas Hugosson, Rebecka Arnsrud Godtman
Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial. European urology 86 (2) (2024)
Stefano Mancon, Heidemarie Ofner, David D'Andrea
Re: Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-year Outcomes from a Randomized Controlled Trial. European urology 86 (2) (2024)
Giuseppe Basile, Andrea Gallioli, Pietro Diana, Anthony Gallagher, Alessandro Larcher, Markus Graefen, Nina Harke, Olivier Traxer, Derya Tilki, Henk Van Der Poel, Esteban Emiliani, Oriol Angerri, Christian Wagner, Francesco Montorsi, Peter Wiklund, Bhaskar Somani, Nicolò Buffi, Alex Mottrie, Evangelos Liatsikos, Alberto Breda
Current Standards for Training in Robot-assisted Surgery and Endourology: A Systematic Review. European urology 86 (2) (2024)
Behnam Shakiba
Re: Emilien Seizilles de Mazancourt, Juliette Cotte, Caroline Plassais, et al. Sexual and Moral Harassment of French Urologists in Training and Barriers to Reporting: Results from a National Survey. Eur Urol. 2024;85:e162-e163. European urology 86 (2) (2024)
Qi-Fei Deng, Yuan-Yuan Bao, Yuan-Yuan Yang, Chang-Kun Mao
Re: David Musheyev, Alexander Pan, Stacy Loeb, Abdo E. Kabarriti. How Well Do Artificial Intelligence Chatbots Respond to the Top Search Queries About Urological Malignancies? Eur Urol 2023;85:13-6. European urology 86 (2) (2024)
Aimin Jiang, Ying Liu, Chen Cai, Peng Luo, Linhui Wang
Re: Stereotactic Ablative Body Radiotherapy for Primary Kidney Cancer (TROG 15.03 FASTRACK II): A Non-randomised Phase 2 Trial. European urology 86 (2) (2024)
Laura Elst, Gino Philips, Kaat Vandermaesen, Ayse Bassez, Francesca Lodi, Manon T A Vreeburg, Oscar R Brouwer, Rogier Schepers, Thomas Van Brussel, Sambit K Mohanty, Anil V Parwani, Lien Spans, Isabelle Vanden Bempt, Gerd Jacomen, Marcella Baldewijns, Diether Lambrechts, Maarten Albersen
Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization. European urology 86 (2) (2024)
Jim C Hu, Mohamad E Allaf, Andrew J Vickers, Edward M Schaeffer
Reply to Giancarlo Marra, Marco Oderda, Paolo Gontero, and Lorenzo Richiardi's Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61-68. European urology 86 (2) (2024)
Markus Grabbert, Nikolaos Liakos, Christian Gratzke
Re: Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer. European urology 86 (2) (2024)
Giancarlo Marra, Marco Oderda, Paolo Gontero, null null
Re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61-68. European urology 86 (2) (2024)
Derya Tilki, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann M Henry, Michael Lardas, Geert J L H van Leenders, Matthew Liew, Estefania Linares Espinos, Jan Oldenburg, Inge M van Oort, Daniela E Oprea-Lager, Guillaume Ploussard, Matthew J Roberts, Olivier Rouvière, Ivo G Schoots, Natasha Schouten, Emma J Smith, Johan Stranne, Thomas Wiegel, Peter-Paul M Willemse, Philip Cornford
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. European urology 86 (2) (2024)
Emilien Seizilles de Mazancourt, Kevin Kaulanjan
Reply to Behnam Shakiba's Letter to the Editor re: Emilien Seizilles de Mazancourt, Juliette Cotte, Caroline Plassais, et al. Sexual and Moral Harassment of French Urologists in Training and Barriers to Reporting: Results from a National Survey. Eur Urol. 2024;85:e162-e163. European urology 86 (2) (2024)
Behnam Shakiba
Re: Emilien Seizilles de Mazancourt, Juliette Cotte, Caroline Plassais, et al. Sexual and Moral Harassment of French Urologists in Training and Barriers to Reporting: Results from a National Survey. Eur Urol. 2024;85:e162-e163. European urology 86 (2) (2024)
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic, Laura Peralta, Yingbei Chen, Robert A Lefkowitz, Neil J Shah, Colette N Owens, Deaglan J McHugh, David H Aggen, Andrew L Laccetti, Ritesh R Kotecha, Darren R Feldman, Robert J Motzer
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial. European urology 86 (2) (2024)
Olivier Cussenot, Antoine Chambaz, Freddie C Hamdy
Re: Annika Herlemann, Janet E. Cowan, Samuel L. Washington 3rd, et al. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2024;85:565-573. European urology 86 (2) (2024)
Nicholas Raison, Prokar Dasgupta, Thomas Knoll
Insights into Training Standards for Robot-assisted Surgery and Endourology: A Perspective for Both Urologists and Trainees. European urology 86 (2) (2024)
Christian D Fankhauser, Marian S Wettstein, Christoph Würnschimmel, Maarten van Smeden, Noel W Clarke
Re: External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort. European urology 86 (2) (2024)
Derya Tilki, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann M Henry, Michael Lardas, Geert J L H van Leenders, Matthew Liew, Estefania Linares Espinos, Jan Oldenburg, Inge M van Oort, Daniela E Oprea-Lager, Guillaume Ploussard, Matthew J Roberts, Olivier Rouvière, Ivo G Schoots, Natasha Schouten, Emma J Smith, Johan Stranne, Thomas Wiegel, Peter-Paul M Willemse, Philip Cornford
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. European urology 86 (2) (2024)
Jeremy Yuen-Chun Teoh, Cheung-Hing Cheng, Chiu-Fung Tsang, Joseph Kai-Man Li, Bryan Kwun-Chung Cheng, Wilson Hoi-Chak Chan, Wayne Kwun-Wai Chan, Trevor Churk-Fai Li, Yi Chiu, Man-Chung Law, Clarence Lok-Hei Leung, Brian Sze-Ho Ho, Chris Yue-Kit Lee, Ronald Cheong-Kin Chan, Eddie Shu-Yin Chan, Marco Tsz-Yeung Chan, James Hok-Leung Tsu, Ho-Man Tam, Kin-Man Lam, Hing-Shing So, Chak-Lam Cho, Chi-Man Ng, Chun-Ki Chan, Pak-Ling Liu, Ringo Wing-Hong Chu, Ada Tsui-Lin Ng, Sau-Kwan Chu, Chi-Hang Yee, Ming-Kwong Yiu, Ka-Lun Lo, Wing-Hang Au, Wai-Kit Ma, Peter Ka-Fung Chiu, Hilda Sze-Wan Kwok, Siu-Ying Yip, Chi-Ho Leung, Chi-Fai Ng, null null
Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial. European urology 86 (2) (2024)
Aimin Jiang, Ying Liu, Chen Cai, Peng Luo, Linhui Wang
Re: Stereotactic Ablative Body Radiotherapy for Primary Kidney Cancer (TROG 15.03 FASTRACK II): A Non-randomised Phase 2 Trial. European urology 86 (2) (2024)
Giuseppe Basile, Andrea Gallioli, Pietro Diana, Anthony Gallagher, Alessandro Larcher, Markus Graefen, Nina Harke, Olivier Traxer, Derya Tilki, Henk Van Der Poel, Esteban Emiliani, Oriol Angerri, Christian Wagner, Francesco Montorsi, Peter Wiklund, Bhaskar Somani, Nicolò Buffi, Alex Mottrie, Evangelos Liatsikos, Alberto Breda
Current Standards for Training in Robot-assisted Surgery and Endourology: A Systematic Review. European urology 86 (2) (2024)
Nicholas Raison, Prokar Dasgupta, Thomas Knoll
Insights into Training Standards for Robot-assisted Surgery and Endourology: A Perspective for Both Urologists and Trainees. European urology 86 (2) (2024)
Jad Chahoud, Xiaoqing Yu, Andrea Necchi, Philippe E Spiess
TP53 Mutations Emerge as a Critical Biomarker in Penile Cancer, Superseding Human Papillomavirus Status. European urology 86 (2) (2024)
Viria Beccia, Giada Pinterpe, Roberto Iacovelli
Re: Thomas Powles, Zoe June Assaf, Viraj Degaonkar, et al. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma. Eur Urol 2024;85:114-22. European urology 86 (2) (2024)
Giancarlo Marra, Marco Oderda, Paolo Gontero, null null
Re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61-68. European urology 86 (2) (2024)
Nicholas G Nickols, Sonny Tsai, Nathanael Kane, Samantha Tran, Leila Ghayouri, Silvia Diaz-Perez, May Thein, Nancy Anderson-Berman, Jeanie Eason, Amar U Kishan, Michael L Steinberg, Robert E Reiter, Steve P Lee, Greg E Gin, Robert Kwon, Michael G Chang, Hann-Hsiang Chao, Abhiskek A Solanki, Rachael Sexton, Michael Lewis, William Lorentz, Michael K Cheung, Diana L Gage, Sai Duriseti, Luca Valle, Gholam Berenji, William J Aronson, Isla P Garraway, Matthew B Rettig
Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer. European urology 86 (2) (2024)
Emilien Seizilles de Mazancourt, Kevin Kaulanjan
Reply to Behnam Shakiba's Letter to the Editor re: Emilien Seizilles de Mazancourt, Juliette Cotte, Caroline Plassais, et al. Sexual and Moral Harassment of French Urologists in Training and Barriers to Reporting: Results from a National Survey. Eur Urol. 2024;85:e162-e163. European urology 86 (2) (2024)